Simplex Trading
BIB icon

Simplex Trading’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Simplex Trading’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.05K Buy
62
+50
+417% +$4.14K ﹤0.01% 7891
2025
Q4 		$957 Buy
+12
New +$888 ﹤0.01% 8036
2025
Q1 		– Sell
-67
Closed -$3K – 8542
2024
Q4 		$3K Buy
+67
New +$3.97K ﹤0.01% 7829
2024
Q3 		– Sell
-553
Closed -$32K – 8484
2024
Q2 		$32K Buy
553
+31
+6% +$1.72K ﹤0.01% 6496
2024
Q1 		$30K Sell
522
-1,957
-79% -$113K ﹤0.01% 6740
2023
Q4 		$141K Buy
2,479
+2,434
+5,409% +$114K ﹤0.01% 5031
2023
Q3 		$2K Buy
+45
New +$2.31K ﹤0.01% 8038
2022
Q4 		– Sell
-1,514
Closed -$72K – 9211
2022
Q3 		$72K Buy
1,514
+1,100
+266% +$58.6K ﹤0.01% 5947
2022
Q2 		$20K Sell
414
-3,761
-90% -$191K ﹤0.01% 7593
2022
Q1 		$258K Sell
4,175
-3,177
-43% -$195K ﹤0.01% 4761
2021
Q4 		$596K Buy
+7,352
New +$630K ﹤0.01% 3560
2021
Q2 		– Sell
-1,016
Closed -$84K – 10033
2021
Q1 		$84K Sell
1,016
-2,970
-75% -$280K ﹤0.01% 5968
2020
Q4 		$344K Sell
3,986
-1,458
-27% -$113K ﹤0.01% 3906
2020
Q3 		$380K Buy
5,444
+1,129
+26% +$80.1K ﹤0.01% 3325
2020
Q2 		$313K Sell
4,315
-841
-16% -$53.7K ﹤0.01% 3473
2020
Q1 		$238K Buy
+5,156
New +$287K ﹤0.01% 3394
2019
Q4 		– Sell
-331
Closed -$14K – 7286
2019
Q3 		$14K Sell
331
-638
-66% -$30.2K ﹤0.01% 6044
2019
Q2 		$50K Buy
969
+885
+1,054% +$44K ﹤0.01% 4859
2019
Q1 		$4K Buy
+84
New +$4.53K ﹤0.01% 6536
2018
Q4 		– Sell
-1,197
Closed -$83K – 7001
2018
Q3 		$83K Buy
+1,197
New +$78.3K ﹤0.01% 4620
2018
Q2 		– Sell
-7,688
Closed -$423K – 7361
2018
Q1 		$423K Buy
7,688
+5,350
+229% +$320K 0.02% 797
2017
Q4 		$131K Sell
2,338
-6,811
-74% -$384K 0.01% 1595
2017
Q3 		$560K Buy
+9,149
New +$520K 0.02% 612
2017
Q1 		– Sell
-2,429
Closed -$96K – 6135
2016
Q4 		$96K Sell
2,429
-21
-0.9% -$897 0.01% 1566
2016
Q3 		$118K Buy
2,450
+1,498
+157% +$71.2K 0.01% 1407
2016
Q2 		$36K Sell
952
-3,681
-79% -$159K ﹤0.01% 2356
2016
Q1 		$189K Buy
+4,633
New +$205K 0.02% 904
2015
Q3 		– Sell
-933
Closed -$84K – 5495
2015
Q2 		$84K Sell
933
-789
-46% -$67.9K 0.01% 1321
2015
Q1 		$136K Buy
+1,722
New +$128K 0.02% 911

Other funds holding BIB

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
KFS
Kaizen Financial Strategies Campbell, California $236M AUM 28.3% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Simplex Trading's BIB Position: Q1 2026 in Review

Simplex Trading increased its ProShares Ultra NASDAQ Biotechnology (BIB) stake by 417% in Q1 2026, buying an estimated $4.14K and bringing the position to 62 shares worth $5.05K. The position accounts for ﹤0.01% of the portfolio, ranked #7891.

Simplex Trading first reported a position in BIB in Q1 2015 and has held it in 29 quarters since. The position peaked at $596K in Q4 2021. 23 funds tracked by Wall St. Rank hold BIB as of Q1 2026.

  • Simplex Trading held 62 shares of ProShares Ultra NASDAQ Biotechnology worth $5.05K as of Q1 2026.
  • Simplex Trading bought 50 ProShares Ultra NASDAQ Biotechnology shares in Q1 2026, an estimated $4.14K.
  • ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7891 holding.
  • Simplex Trading first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2015 and has held it in 29 quarters since.
  • Simplex Trading's ProShares Ultra NASDAQ Biotechnology position peaked at $596K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.